Algert Global LLC Purchases 81,867 Shares of agilon health, inc. (NYSE:AGL)

Algert Global LLC raised its position in shares of agilon health, inc. (NYSE:AGL) by 398.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 102,407 shares of the company’s stock after acquiring an additional 81,867 shares during the period. Algert Global LLC’s holdings in agilon health were worth $670,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. J.Safra Asset Management Corp boosted its position in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the period. Neo Ivy Capital Management bought a new stake in agilon health in the 4th quarter valued at $47,000. CWM LLC grew its position in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in shares of agilon health during the 2nd quarter worth about $60,000. Finally, Bleakley Financial Group LLC bought a new stake in shares of agilon health in the first quarter valued at about $65,000.

agilon health Price Performance

AGL opened at $3.21 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market capitalization of $1.32 billion, a P/E ratio of -4.59 and a beta of 0.54. The company’s 50 day simple moving average is $4.50 and its 200-day simple moving average is $5.38. agilon health, inc. has a one year low of $3.04 and a one year high of $20.37.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the firm earned ($0.04) EPS. The business’s revenue for the quarter was up 38.7% on a year-over-year basis. Sell-side analysts anticipate that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have commented on AGL. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a report on Wednesday. Benchmark restated a “buy” rating and issued a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th. Evercore ISI lifted their price target on shares of agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 9th. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, agilon health has a consensus rating of “Hold” and an average target price of $8.22.

Insider Buying and Selling

In other news, CEO Steven Sell purchased 20,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.20% of the stock is owned by insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.